IL149212A0 - Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate - Google Patents

Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate

Info

Publication number
IL149212A0
IL149212A0 IL14921200A IL14921200A IL149212A0 IL 149212 A0 IL149212 A0 IL 149212A0 IL 14921200 A IL14921200 A IL 14921200A IL 14921200 A IL14921200 A IL 14921200A IL 149212 A0 IL149212 A0 IL 149212A0
Authority
IL
Israel
Prior art keywords
isoquinoline
aminoethyl
bis
amino
liposome formulation
Prior art date
Application number
IL14921200A
Other languages
English (en)
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of IL149212A0 publication Critical patent/IL149212A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14921200A 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate IL149212A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002219A IT1315253B1 (it) 1999-10-22 1999-10-22 Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
PCT/EP2000/010303 WO2001028521A2 (en) 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate

Publications (1)

Publication Number Publication Date
IL149212A0 true IL149212A0 (en) 2002-11-10

Family

ID=11383836

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14921200A IL149212A0 (en) 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate
IL149212A IL149212A (en) 1999-10-22 2002-04-18 The liposome composition of 9,6 - Bis - [(2 - aminoethyl) - amino] benzo [G] isoquinoline - 10,5 - Dion Dimlat

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149212A IL149212A (en) 1999-10-22 2002-04-18 The liposome composition of 9,6 - Bis - [(2 - aminoethyl) - amino] benzo [G] isoquinoline - 10,5 - Dion Dimlat

Country Status (23)

Country Link
US (1) US7449197B2 (de)
EP (1) EP1221940B1 (de)
JP (1) JP2003512313A (de)
KR (1) KR20020063880A (de)
CN (1) CN1164261C (de)
AT (1) ATE335468T1 (de)
AU (1) AU772339B2 (de)
BR (1) BR0014881A (de)
CA (1) CA2386143A1 (de)
CZ (1) CZ20021388A3 (de)
DE (1) DE60029979T2 (de)
EA (1) EA004477B1 (de)
ES (1) ES2269200T3 (de)
HU (1) HUP0203473A3 (de)
IL (2) IL149212A0 (de)
IT (1) IT1315253B1 (de)
MX (1) MXPA02003939A (de)
NO (1) NO20021867L (de)
NZ (1) NZ518005A (de)
PL (1) PL197412B1 (de)
SK (1) SK284247B6 (de)
WO (1) WO2001028521A2 (de)
ZA (1) ZA200203128B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353593A1 (en) * 1998-12-18 2000-06-22 Hadasit Medical Research Services & Development Ltd. Method of administering a compound to multi-drug resistant cells
ITMI20021040A1 (it) 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
CN103479578B (zh) * 2012-06-14 2016-08-03 沈阳药科大学 一种马来酸匹杉琼的脂质体制剂及其制备工艺
CN105596295B (zh) * 2016-01-25 2018-03-16 北京博恩特药业有限公司 马来酸匹杉琼脂质体及其制备方法
CN105997896B (zh) * 2016-05-28 2019-07-05 长沙秋点兵信息科技有限公司 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
JPS6442418A (en) * 1985-12-06 1989-02-14 Yissum Res Dev Co Liposome/anthraquinone drug composition and therapy therewith
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
CA2184834A1 (en) * 1994-03-11 1995-09-14 Yoshiyuki Mori Liposome preparation
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
WO1999011242A1 (en) * 1997-09-04 1999-03-11 Biozone Laboratories, Inc. Oral liposomal delivery system

Also Published As

Publication number Publication date
NZ518005A (en) 2003-10-31
PL197412B1 (pl) 2008-03-31
ITMI992219A1 (it) 2001-04-22
IT1315253B1 (it) 2003-02-03
WO2001028521A3 (en) 2002-04-25
CZ20021388A3 (cs) 2002-08-14
DE60029979T2 (de) 2007-02-22
US20060078607A1 (en) 2006-04-13
EA200200389A1 (ru) 2002-08-29
HUP0203473A2 (hu) 2003-02-28
SK284247B6 (sk) 2004-12-01
PL354610A1 (en) 2004-02-09
CA2386143A1 (en) 2001-04-26
BR0014881A (pt) 2002-06-11
EP1221940B1 (de) 2006-08-09
CN1164261C (zh) 2004-09-01
ZA200203128B (en) 2003-06-05
EP1221940A2 (de) 2002-07-17
MXPA02003939A (es) 2004-06-25
NO20021867D0 (no) 2002-04-19
SK5382002A3 (en) 2002-09-10
KR20020063880A (ko) 2002-08-05
JP2003512313A (ja) 2003-04-02
IL149212A (en) 2006-12-10
ATE335468T1 (de) 2006-09-15
US7449197B2 (en) 2008-11-11
DE60029979D1 (de) 2006-09-21
EA004477B1 (ru) 2004-04-29
AU772339B2 (en) 2004-04-22
AU1514601A (en) 2001-04-30
CN1382039A (zh) 2002-11-27
HUP0203473A3 (en) 2003-12-29
WO2001028521A2 (en) 2001-04-26
NO20021867L (no) 2002-04-19
ES2269200T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
YU84703A (sh) Oralni rastvor aripiprazola
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
HUP0004050A3 (en) Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same
IL138969A0 (en) Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0002404A3 (en) Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use
EP1274443A4 (de) Mizellen
PL343936A1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
WO1997028104A3 (de) Puffersysteme zur stabilisierung pharmazeutischer zubereitungen
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
IL149212A0 (en) Liposome formulation of 6,9-bis- (2-aminoethyl) amino] [g] isoquinoline-5,10-dione dimaleate
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL139817A0 (en) Non-hydrated gabapentin polymorph, a process for the preparation thereof and the use thereof for the preparation of pharmaceutical grade gabapentin
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
EP0842663A4 (de) Ophtalmika
BG106151A (en) Pharmaceutical complex
AP9901472A0 (en) Crystalline pharmaceutical product.
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
ES2131482A1 (es) Formulacion acuosa de bambuterol.
EP0974353A3 (de) Verwendung von Homocysteinderivaten zur Bereitung eines Medikaments zur verhinderung der Bakterienadhesion
AU7220898A (en) Cytotoxic compounds: derivatives of the pyrido{2,3,4-(kl)} acridine ring system
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted